These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16360556)

  • 1. Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    J Clin Epidemiol; 2006 Jan; 59(1):11-7. PubMed ID: 16360556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.
    Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization.
    Caetano PA; Lam JM; Morgan SG
    Clin Ther; 2006 Sep; 28(9):1411-24; discussion 1410. PubMed ID: 17062314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence and persistence with fluticasone propionate/salmeterol combination therapy.
    Bender BG; Pedan A; Varasteh LT
    J Allergy Clin Immunol; 2006 Oct; 118(4):899-904. PubMed ID: 17030244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucoma medication persistence with a fixed combination versus multiple bottles.
    Higginbotham EJ; Hansen J; Davis EJ; Walt JG; Guckian A
    Curr Med Res Opin; 2009 Oct; 25(10):2543-7. PubMed ID: 19731993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
    Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.
    Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G
    J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension.
    Robertson TA; Cooke CE; Wang J; Shaya FT; Lee HY
    Am J Manag Care; 2008 Nov; 14(11):710-6. PubMed ID: 18999905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
    Taira DA; Wong KS; Frech-Tamas F; Chung RS
    Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
    Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
    Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence with hypertension treatment among community-dwelling BC seniors.
    Morgan SG; Yan L
    Can J Clin Pharmacol; 2004; 11(2):e267-73. PubMed ID: 15596883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D; Lopez J; Meier J
    Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with drug adherence and blood pressure control in patients with hypertension.
    Morris AB; Li J; Kroenke K; Bruner-England TE; Young JM; Murray MD
    Pharmacotherapy; 2006 Apr; 26(4):483-92. PubMed ID: 16553506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gap analysis approach to assess patient persistence with glaucoma medication.
    Lee PP; Walt JG; Chiang TH; Guckian A; Keener J
    Am J Ophthalmol; 2007 Oct; 144(4):520-4. PubMed ID: 17692273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of refill adherence and health care use among adults with hypertension in an urban health care system.
    Stroupe KT; Teal EY; Tu W; Weiner M; Murray MD
    Pharmacotherapy; 2006 Jun; 26(6):779-89. PubMed ID: 16716131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.